4.7 Article

Oral Glucose Tolerance Test-based Measures of Insulin Secretory Response in Pregnancy

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 107, Issue 5, Pages E1871-E1878

Publisher

ENDOCRINE SOC
DOI: 10.1210/clinem/dgac041

Keywords

pregnancy; gestational diabetes; insulin; glucose

Funding

  1. NICHD [HD22965-19]
  2. NCRR CTSA [Ul1 RR 024989]
  3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23DK113218]
  4. Robert Wood Johnson Foundation's Harold Amos Medical Faculty Development Program
  5. Harvard Catalyst/Harvard University's Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL 1TR002541]
  6. Harvard University

Ask authors/readers for more resources

The study found that Stumvoll and AUC(ins)/AUC(glu) are valid OGTT-based measures of insulin secretory response during pregnancy, and can effectively reflect the changes in insulin secretion.
Background Oral glucose tolerance test (OGTT)-based measures of insulin secretory response have not been validated in pregnancy. Methods In a secondary analysis of a longitudinal study, participants were studied prepregnancy (n = 40), in early pregnancy (n = 36; 12-14 weeks' gestation), and in late pregnancy (n = 36; 34-36 weeks' gestation). Participants underwent an OGTT, an intravenous glucose tolerance test (IVGTT), and a hyperinsulinemic-euglycemic clamp at each timepoint. We calculated homeostatic model assessment of beta-cell function (HOMA-2B), insulinogenic index (IGI), corrected insulin response (CIR), ratio of the area under the insulin curve and the area under the glucose curve (AUC(ins)/AUC(glu)), and Stumvoll first-phase estimate (Stumvoll) from OGTT insulin and glucose levels. We used Pearson correlation to compare measures from OGTT and IVGTT. We used mixed effects models to examine longitudinal changes in insulin secretory response. Results Stumvoll was the only OGTT-based measure that was significantly correlated with first-phase insulin response prior to and across gestation (prepregnancy: r = 0.44, P = 0.01; early pregnancy: r = 0.67, P = 0.0001; late pregnancy: r = 0.67, P = 0.0001). In early and late pregnancy, AUC(ins)/AUC(glu) had the strongest correlation with first-phase insulin response (early pregnancy: r = 0.79, P < 0.0001; late pregnancy: r = 0.69, P < 0.0001) but was not significantly correlated prepregnancy. IGI and CIR were significantly correlated with first-phase insulin response prepregnancy (IGI: r = 0.50, P = 0.005; CIR r = 0.47, P = 0.008) and in late pregnancy (IGI: r = 0.68, P = 0.0001; CIR r = 0.57, P = 0.002) but not in early pregnancy. HOMA-2B was the weakest correlate of first-phase insulin response. Stumvoll and AUC(ins)/AUC(glu) recapitulated the longitudinal changes in insulin secretory response observed by IVGTT. Conclusions Stumvoll and AUC(ins)/AUC(glu) are valid OGTT-based insulin secretory response measures for pregnancy studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available